SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project

Mostrar otras versiones (1)

INTRODUCTION: Several vaccines against SARS-CoV-2 are currently in use and are recommended in inflammatory bowel disease (IBD) patients. Data are scarce about the gastroenterologists and IBD patient's acceptance of SARS-CoV-2 vaccines. The aim of the study was to evaluate the intention to get v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreiro-Iglesias, Rocío, Hernández-Camba, Alejandro, Serrano Labajos, Ruth, Rodríguez-Lago, Iago, Zabana, Yamile, Barreiro-de Acosta, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386133/
https://www.ncbi.nlm.nih.gov/pubmed/34453969
http://dx.doi.org/10.1016/j.gastrohep.2021.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386133/
https://www.ncbi.nlm.nih.gov/pubmed/34453969
http://dx.doi.org/10.1016/j.gastrohep.2021.08.004

Ejemplares similares